Jerome Rollin
Overview
Explore the profile of Jerome Rollin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
883
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vinhais da Silva A, Chesseron S, Benouna O, Rollin J, Roger S, Bourguignon T, et al.
Am J Physiol Heart Circ Physiol
. 2025 Jan;
328(3):H550-H564.
PMID: 39884315
Pathological left ventricular remodeling is a complex process following an acute myocardial infarction, leading to architectural disorganization of the cardiac tissue. This phenomenon is characterized by sterile inflammation and the...
2.
Duret T, Elmallah M, Rollin J, Gatault P, Jiang L, Roger S
Biomed J
. 2024 Nov;
:100805.
PMID: 39510381
Cell-to-cell communication is a major process for accommodating cell functioning to changes in the environments and to preserve tissue and organism homeostasis. It is achieved by different mechanisms characterized by...
3.
Mazharian A, Bertin O, Sarkar A, Augros J, Bornert A, Loubiere C, et al.
bioRxiv
. 2024 May;
PMID: 38798354
Platelets are highly reactive fragments of megakaryocytes that play a fundamental role in thrombosis and hemostasis. Predictably, all conventional anti-platelet therapies elicit bleeding, raising the question whether the thrombotic activity...
4.
Vayne C, Rollin J, Clare R, Daka M, Atsouawe M, Guery E, et al.
J Thromb Haemost
. 2024 May;
22(8):2306-2315.
PMID: 38762021
Background: Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a complication of adenoviral-based vaccine against SARS-CoV-2 due to prothrombotic immunoglobulin (Ig) G antibodies to platelet factor 4 (PF4) and may be difficult...
5.
Giles J, Rollin J, Martinez K, Selleng K, Thiele T, Pouplard C, et al.
Thromb Res
. 2023 Aug;
229:198-208.
PMID: 37541168
Heparin-induced thrombocytopenia (HIT) is an antibody-mediated immune response against platelet factor 4 (PF4) bound to heparin anticoagulants. A priori identification of patients at-risk for HIT remains elusive and a number...
6.
Sarkar A, Khandelwal S, Koma G, Kim H, Gruel Y, Rollin J, et al.
Blood Adv
. 2023 May;
7(15):4112-4123.
PMID: 37196641
Heparin-induced thrombocytopenia (HIT) is characterized by thrombocytopenia associated with a highly prothrombotic state due to the development of pathogenic antibodies that recognize human platelet factor 4 (hPF4) complexed with various...
7.
Cai Z, Bdeir K, Yarovoi S, Rauova L, Arepally G, Khandelwal S, et al.
J Thromb Haemost
. 2023 Jan;
21(3):652-666.
PMID: 36696211
Background: Heparin-induced thrombocytopenia (HIT) is a serious thrombotic disorder caused by ultralarge immune complexes (ULICs) containing platelet factor 4 (PF4) and heparin that form the HIT antigen, together with a...
8.
Maruani A, Moineau A, Boccara O, Mazereeuw-Hautier J, Leducq S, Bessis D, et al.
Br J Dermatol
. 2023 Jan;
188(1):152-154.
PMID: 36689523
No abstract available.
9.
Chen L, Schirmer U, Widder M, Gruel Y, Rollin J, Zipfel P, et al.
J Mater Chem B
. 2022 Sep;
10(38):7708-7716.
PMID: 36069407
Heparin-induced thrombocytopenia (HIT) is caused by newly formed platelet-activating antibodies against complexes formed between platelet factor 4 (PF4) and heparin (H). HIT can result in life-threatening complications; thus, early detection...
10.
Rollin J, Charuel N, Gruel Y, Billy S, Guery E, May M, et al.
J Thromb Haemost
. 2022 Aug;
20(11):2646-2655.
PMID: 35971886
Background: The diagnosis of heparin-induced thrombocytopenia (HIT) requires functional assays to demonstrate that platelet factor 4 (PF4)-specific antibodies activate platelets, typically when therapeutic heparin (H) concentrations are tested ("classical" pattern)....